• FirefoxUpgrade to the new Firefox »
  •  Dow Up0.03% Nasdaq Up0.17%

    Myriad Genetics Inc. (MYGN)

    -NasdaqGS
    36.50 Up 0.28(0.77%) Dec 24, 1:00PM EST
    Add to Portfolio
    Analyst OpinionGet Analyst Opinion for:
    Recommendation Summary*
    Mean Recommendation (this week):2.7
    Mean Recommendation (last week):2.7
    Change:0.0

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Price Target Summary
    Mean Target:37.75
    Median Target:37.50
    High Target:50.00
    Low Target:25.00
    No. of Brokers:12

    Data provided by Thomson/First Call

    Upgrades & Downgrades History
    DateResearch FirmActionFromTo
    Apr 4, 2014MizuhoUpgradeNeutralBuy
    Feb 5, 2014Ladenburg ThalmannDowngradeBuyNeutral
    Dec 30, 2013MizuhoDowngradeBuyNeutral
    Oct 1, 2013Ladenburg ThalmannUpgradeNeutralBuy
    Jun 7, 2013Cantor FitzgeraldInitiated Buy
    May 8, 2013MizuhoUpgradeNeutralBuy
    Feb 5, 2013Ladenburg ThalmannDowngradeBuyNeutral
    Dec 3, 2012MizuhoDowngradeBuyNeutral
    Oct 1, 2012WallachBethInitiated Buy
    Nov 2, 2011TiconderogaUpgradeNeutralBuy

    More Upgrades & Downgrades for MYGN

    Data provided by Briefing.com - Take a free trial
    Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

    Recommendation Trends
    Current MonthLast MonthTwo Months AgoThree Months Ago
    Strong Buy2222
    Buy4444
    Hold10101010
    Underperform3322
    Sell0000

    Data provided by Thomson/First Call


    Currency in USD.